These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33985395)

  • 1. An overview of ProTide technology and its implications to drug discovery.
    Serpi M; Pertusati F
    Expert Opin Drug Discov; 2021 Oct; 16(10):1149-1161. PubMed ID: 33985395
    [No Abstract]   [Full Text] [Related]  

  • 2. The ProTide Prodrug Technology: From the Concept to the Clinic.
    Mehellou Y; Rattan HS; Balzarini J
    J Med Chem; 2018 Mar; 61(6):2211-2226. PubMed ID: 28792763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ProTides Boom.
    Mehellou Y
    ChemMedChem; 2016 Jun; 11(11):1114-6. PubMed ID: 27159529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphoramidates and phosphonamidates (ProTides) with antiviral activity.
    Slusarczyk M; Serpi M; Pertusati F
    Antivir Chem Chemother; 2018; 26():2040206618775243. PubMed ID: 29792071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancement of Prodrug Approaches for Nucleotide Antiviral Agents.
    Li Y; Yang B; Quan Y; Li Z
    Curr Top Med Chem; 2021; 21(32):2909-2927. PubMed ID: 34323189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of phosphoramidate prodrugs: ProTide approach.
    Serpi M; Madela K; Pertusati F; Slusarczyk M
    Curr Protoc Nucleic Acid Chem; 2013 Jun; Chapter 15():15.5.1-15.5.15. PubMed ID: 23775807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced Prodrug Strategies in Nucleoside and Non-Nucleoside Antiviral Agents: A Review of the Recent Five Years.
    Sinokrot H; Smerat T; Najjar A; Karaman R
    Molecules; 2017 Oct; 22(10):. PubMed ID: 29035325
    [No Abstract]   [Full Text] [Related]  

  • 8. Aryloxy phosphoramidate triesters: a technology for delivering monophosphorylated nucleosides and sugars into cells.
    Mehellou Y; Balzarini J; McGuigan C
    ChemMedChem; 2009 Nov; 4(11):1779-91. PubMed ID: 19760699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Could 5'-N and S ProTide analogues work as prodrugs of antiviral agents?
    Procházková E; Hřebabecký H; Dejmek M; Šála M; Šmídková M; Tloušťová E; Zborníková E; Eyer L; Růžek D; Nencka R
    Bioorg Med Chem Lett; 2020 Feb; 30(4):126897. PubMed ID: 31882298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of Selected Nucleoside Analogue ProTides against Zika Virus in Human Neural Stem Cells.
    Bernatchez JA; Coste M; Beck S; Wells GA; Luna LA; Clark AE; Zhu Z; Hecht D; Rich JN; Sohl CD; Purse BW; Siqueira-Neto JL
    Viruses; 2019 Apr; 11(4):. PubMed ID: 31010044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of phosphorodiamidate prodrugs of antiviral and anticancer nucleosides.
    McGuigan C; Bourdin C; Derudas M; Hamon N; Hinsinger K; Kandil S; Madela K; Meneghesso S; Pertusati F; Serpi M; Slusarczyk M; Chamberlain S; Kolykhalov A; Vernachio J; Vanpouille C; Introini A; Margolis L; Balzarini J
    Eur J Med Chem; 2013; 70():326-40. PubMed ID: 24177359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleoside Phosphate and Phosphonate Prodrug Clinical Candidates.
    Thornton PJ; Kadri H; Miccoli A; Mehellou Y
    J Med Chem; 2016 Dec; 59(23):10400-10410. PubMed ID: 27559756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and anti-herpetic activity of phosphoramidate ProTides.
    Maiti M; Persoons L; Andrei G; Snoeck R; Balzarini J; Herdewijn P
    ChemMedChem; 2013 Jun; 8(6):985-93. PubMed ID: 23606629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicinal chemistry of nucleoside phosphonate prodrugs for antiviral therapy.
    Pertusati F; Serpi M; McGuigan C
    Antivir Chem Chemother; 2012 May; 22(5):181-203. PubMed ID: 22182785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphoramidate ProTides of the anticancer agent FUDR successfully deliver the preformed bioactive monophosphate in cells and confer advantage over the parent nucleoside.
    McGuigan C; Murziani P; Slusarczyk M; Gonczy B; Vande Voorde J; Liekens S; Balzarini J
    J Med Chem; 2011 Oct; 54(20):7247-58. PubMed ID: 21892829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symmetrical diamidate prodrugs of nucleotide analogues for drug delivery.
    Pertusati F; McGuigan C; Serpi M
    Curr Protoc Nucleic Acid Chem; 2015 Mar; 60():15.6.1-15.6.10. PubMed ID: 25754890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Heights for ProTides?
    Ballatore C
    J Med Chem; 2021 Nov; 64(22):16422-16424. PubMed ID: 34783565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of the phosphoramidate ProTide approach to 4'-azidouridine confers sub-micromolar potency versus hepatitis C virus on an inactive nucleoside.
    Perrone P; Luoni GM; Kelleher MR; Daverio F; Angell A; Mulready S; Congiatu C; Rajyaguru S; Martin JA; Levêque V; Le Pogam S; Najera I; Klumpp K; Smith DB; McGuigan C
    J Med Chem; 2007 Apr; 50(8):1840-9. PubMed ID: 17367121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of the phosphoramidate ProTide approach to the antiviral drug ribavirin.
    Derudas M; Brancale A; Naesens L; Neyts J; Balzarini J; McGuigan C
    Bioorg Med Chem; 2010 Apr; 18(7):2748-55. PubMed ID: 20207546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactive cyclic intermediates in the ProTide prodrugs activation: trapping the elusive pentavalent phosphorane.
    Procházková E; Navrátil R; Janeba Z; Roithová J; Baszczyňski O
    Org Biomol Chem; 2019 Jan; 17(2):315-320. PubMed ID: 30543240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.